Reuters
Lykos' longtime CEO to step down in latest shakeup after MDMA drug setback
Lykos Therapeutics said on Thursday longtime CEO Amy Emerson would step down from the role, in the latest shakeup after the U.S. health regulator declined to approve its MDMA-based treatment for post-traumatic stress disorder.
6 小時前